CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 50 enrolled
Drug / intervention
Loceryl NL + Cosmetic varnish +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02321098
NCT02321098Phase 4Completed
CompareCT.gov

Determination of Antifungal Activity of Loceryl Nail Lacquer 5% When Used Concomitantly With a Cosmetic Nail Varnish Compared to a Loceryl Nail Lacquer (NL) 5% Alone in Treatment of Toenail Distal Subungual Onychomycosis

Galderma R&D·interventional·Posted Dec 22, 2014·Updated Jan 19, 2023

In Brief

A Phase 4 clinical trial evaluating Loceryl NL + Cosmetic varnish, Loceryl NL 12 weeks, and 1 other intervention for Foot Dermatoses. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The main objective is to compare efficacy, in terms of antifungal activity of Loceryl Nail Lacquer associated with a Cosmetic Varnish and Loceryl Nail Lacquer alone, in the treatment of mild to moderate toenail Distal Subungual Onychomycosis. The second objective of this study will be photographic follow-up of clinical improvement and cure after the initial treatment period of 12 weeks, for 15 additional months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFoot Dermatoses
CountriesIceland
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 22, 2014
Enrollment StartFeb 1, 2014
Primary CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 11.5 years ago

Interventions

Loceryl NL + Cosmetic varnishdrug

Loceryl NL + Cosmetic varnish once/week for 12 weeks

Loceryl NL 12 weeksdrug

Loceryl NL once/week for 12 weeks

Loceryl NL 15 monthsdrug

Loceryl once/week for additional 15 months